Vinciane Marchand

Title: Vinciane Marchand: Innovator in Lymphoma Classification

Introduction

Vinciane Marchand is a notable inventor based in Rouen, France. She has made significant contributions to the field of medical research, particularly in the classification of diffuse large B-cell lymphomas (DLBCLs). Her innovative work has the potential to enhance diagnostic accuracy and treatment strategies for patients suffering from this type of cancer.

Latest Patents

Vinciane Marchand holds a patent for her invention titled "Methods and kits for classifying diffuse large B-cell lymphomas (DLBCLs) into GCB-DLBCLs or into ABC-DLBCLs." This patent describes a method for classifying DLBCLs by determining the expression levels of ten specific genes in tumor tissue samples. The genes involved in this classification process include NEK6, IRF4, IGHM, LMO2, FOXP1, TNFRSF9, BCL6, TNFRSF13B, CCND2, and MYBL1. This innovative approach utilizes a Reverse Transcriptase Multiplex Ligation dependent Probe Amplification (RT-MLPA) assay, which represents a significant advancement in lymphoma diagnostics.

Career Highlights

Throughout her career, Vinciane Marchand has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the University of Rouen (Université De Rouen). Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Vinciane has collaborated with notable colleagues, including Fabrice Jardin and Philippe Ruminy. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of her research.

Conclusion

Vinciane Marchand is a pioneering inventor whose work in lymphoma classification is making a significant difference in the medical field. Her innovative methods and dedication to research continue to inspire advancements in cancer diagnostics and treatment.